HK153395A - Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor - Google Patents

Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor

Info

Publication number
HK153395A
HK153395A HK153395A HK153395A HK153395A HK 153395 A HK153395 A HK 153395A HK 153395 A HK153395 A HK 153395A HK 153395 A HK153395 A HK 153395A HK 153395 A HK153395 A HK 153395A
Authority
HK
Hong Kong
Prior art keywords
hcmv
antibodies
processor
production
recombinant vectors
Prior art date
Application number
HK153395A
Other languages
English (en)
Inventor
Geoffrey Lilley Smith
Martin Patrick Cranage
Barclay George Barrell
Original Assignee
Cogent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27262944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK153395(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB868605646A external-priority patent/GB8605646D0/en
Priority claimed from GB868629988A external-priority patent/GB8629988D0/en
Application filed by Cogent Ltd filed Critical Cogent Ltd
Publication of HK153395A publication Critical patent/HK153395A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK153395A 1986-03-07 1995-09-28 Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor HK153395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868605646A GB8605646D0 (en) 1986-03-07 1986-03-07 Vaccines
GB868621081A GB8621081D0 (en) 1986-03-07 1986-09-01 Vaccines
GB868629988A GB8629988D0 (en) 1986-12-16 1986-12-16 Vaccines

Publications (1)

Publication Number Publication Date
HK153395A true HK153395A (en) 1995-10-06

Family

ID=27262944

Family Applications (1)

Application Number Title Priority Date Filing Date
HK153395A HK153395A (en) 1986-03-07 1995-09-28 Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor

Country Status (8)

Country Link
EP (1) EP0236145B2 (es)
JP (4) JP3254127B2 (es)
CA (1) CA1335429C (es)
DE (1) DE3768833D1 (es)
ES (1) ES2039233T5 (es)
GB (1) GB2194538B (es)
HK (1) HK153395A (es)
WO (1) WO1987005326A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
US5124440A (en) * 1986-11-24 1992-06-23 The Childrens Hospital, Inc. Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus
JPH02504551A (ja) * 1987-08-07 1990-12-20 ザ・チルドレンズ・ホスピタル，インコーポレイテッド サイトメガロウイルスの糖タンパク質ａと反応性のモノクローナル抗体
JP2607712B2 (ja) * 1988-01-29 1997-05-07 カイロン コーポレイション 組換えｃｍｖ中和タンパク
US5547834A (en) * 1988-01-29 1996-08-20 Chiron Corporation Recombinant CMV neutralizing proteins
WO1989010965A2 (en) * 1988-05-03 1989-11-16 The Upjohn Company Glycoprotein h of herpes viruses
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
DK0389286T3 (da) * 1989-03-24 1996-11-18 Wistar Inst Rekombinant-cytomegalovirus-vaccine
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
WO1991004277A1 (en) * 1989-09-14 1991-04-04 Children's Biomedical Research Institute Monoclonal antibodies specific to cytomegalovirus glycoprotein
US5997878A (en) * 1991-03-07 1999-12-07 Connaught Laboratories Recombinant poxvirus-cytomegalovirus, compositions and uses
JPH0868587A (ja) * 1994-08-30 1996-03-12 Hitachi Ltd 冷蔵庫の機械室構造
AU2809897A (en) 1996-04-23 1997-11-12 Wistar Institute Of Anatomy And Biology, The Novel human cytomegalovirus dna constructs and uses therefor
AU735981B2 (en) 1996-07-12 2001-07-19 Akzo Nobel N.V. Peptide reagent for the detection of human cytomegalovirus (CMV)
WO2005028496A2 (en) 2003-09-12 2005-03-31 Antigenics, Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US7491490B2 (en) * 2004-05-12 2009-02-17 Wisconsin Alumni Research Foundation Cytomegalovirus disintegrin-like peptides
TW201738562A (zh) * 2009-05-28 2017-11-01 亞培生物股份有限公司 體外病原體檢驗技術
WO2011053798A2 (en) * 2009-10-30 2011-05-05 The Administrators Of The Tulane Educational Fund Peptide compositions and methods for inhibiting herpesvirus infection
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
US11364292B2 (en) 2015-07-21 2022-06-21 Modernatx, Inc. CHIKV RNA vaccines
MD3718565T2 (ro) 2015-10-22 2022-09-30 Modernatx Inc Vaccinuri împotriva virusului respirator
WO2017070624A1 (en) 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
JP6921833B2 (ja) 2015-10-22 2021-08-18 モデルナティーエックス， インコーポレイテッド ヒトサイトメガロウイルスワクチン
EP3528821A4 (en) 2016-10-21 2020-07-01 ModernaTX, Inc. VACCINE AGAINST THE HUMANE CYTOMEGALOVIRUS
EP3551193A4 (en) 2016-12-08 2020-08-19 Modernatx, Inc. NUCLEIC ACID VACCINES AGAINST RESPIRATORY VIRUSES
EP3582790A4 (en) 2017-02-16 2020-11-25 ModernaTX, Inc. VERY POWERFUL IMMUNOGENIC COMPOSITIONS
WO2019055807A1 (en) 2017-09-14 2019-03-21 Modernatx, Inc. RNA VACCINES AGAINST ZIKA VIRUS
US11351242B1 (en) 2019-02-12 2022-06-07 Modernatx, Inc. HMPV/hPIV3 mRNA vaccine composition
US11406703B2 (en) 2020-08-25 2022-08-09 Modernatx, Inc. Human cytomegalovirus vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002077A1 (en) * 1982-11-30 1984-06-07 Us Health Process for producing poxvirus recombinants for expression of foreign genes

Also Published As

Publication number Publication date
JP3254127B2 (ja) 2002-02-04
ES2039233T5 (es) 1998-07-16
GB2194538A (en) 1988-03-09
JP3254128B2 (ja) 2002-02-04
CA1335429C (en) 1995-05-02
JP3506683B2 (ja) 2004-03-15
JPH0994096A (ja) 1997-04-08
JP2002176992A (ja) 2002-06-25
WO1987005326A1 (en) 1987-09-11
JPH0994095A (ja) 1997-04-08
ES2039233T3 (es) 1993-09-16
EP0236145B2 (en) 1998-03-11
DE3768833D1 (de) 1991-05-02
GB2194538B (en) 1990-10-24
JP3217019B2 (ja) 2001-10-09
GB8724676D0 (en) 1987-11-25
JPH10113192A (ja) 1998-05-06
EP0236145A1 (en) 1987-09-09
EP0236145B1 (en) 1991-03-27

Similar Documents

Publication Publication Date Title
HK153395A (en) Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
IL87581A0 (en) Recombinant avipox virus
GB2178041B (en) Antigenic modification of peptides
GB8610551D0 (en) Polypeptide & protein derivatives
GB8721424D0 (en) Recombinant expression method
HK164195A (en) Novel polypeptide
IL75927A0 (en) Retroviral vaccines and vectors and methods for their construction
HUT44619A (en) Process for preparing monoclonal antibodies and peptides suitable for the treatment and detection of hiv infections
IL101780A0 (en) Recombinant avipox virus,the culture of cells infected with this virus and vaccines for poultry derived from this virus
IL82935A0 (en) Secretion of heterologous proteins from yeast
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
PT86091A (en) Process for the preparation of novel peptides
AU7816987A (en) Expression of hepatitis B viral antigens from recombinant baculovirus vectors
EP0404835A4 (en) Novel recombinant vaccinia virus expression vectors and method of selecting same
PT87137A (pt) Process for the preparation of an immunogenic polypeptide express by a recombinant yeast
IE980257A1 (en) Method of using eukaryotic expression vectors comprising the bk virus enhancer
IL79880A0 (en) Recombinant virus
IL86699A0 (en) Cell system for expression of recombinant protein without production of virus
PT86162A (en) Recombinant protein expression
PT85033A (en) Process for the preparation of novel peptides
PL261904A1 (en) Procedure for the receiving of ionones and methyl ionones
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies
HU911919D0 (en) Process and recombinant dna for the production of chimaera antibodies

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20070308